Skip to main content

Table 1 Participant characteristics by viral load status, North West Province, South Africa, 2014a

From: The role of drug resistance in poor viral suppression in rural South Africa: findings from a population-based study

 Not Suppressed
(≥ 5000 copies/ml)
wgt n = 7981
Suppressed
(<  5000 copies/ml)
wgt n = 4976
 
wgt %95% CIwgt %95% CIP-value
Overall61.6(51.4–70.9)38.4(29.2–48.6) 
Sex
 Male51.1(41.0–61.1)21.1(10.4–38.2)0.003
 Female48.9(38.9–59.1)78.9(61.8–89.6) 
Age group
 18–29 Years22.2(11.4–38.7)19.0(9.2–35.1)0.868
 30–39 Years45.0(31.0–59.9)42.7(28.1–58.7) 
 40–49 Years32.8(22.1–45.6)38.3(24.5–54.4) 
Education
 Primary or Less30.2(20.3–42.4)35.3(21.6–52.0)0.759
 Some Secondary39.3(30.0–49.5)39.8(28.0–53.0) 
 Completed Secondary30.5(22.2–40.2)24.8(13.2–41.8) 
Prior knowledge of HIV serostatusb
 Known Positive54.2(41.7–66.1)86.0(68.6–94.6)0.005
 Unknown45.8(33.9–58.3)14.0(5.4–31.4)e 
ART initiationb
 No19.7(10.4–34.3)4.8(1.4–15.1)0.040
 Yes80.3(65.7–89.6)95.3(85.0–98.6) 
Time on ARTb
  < 1 year23.4(14.4–35.9)13.8(7.4–24.3)0.134
 1–3 years42.9(29.4–57.5)33.7(18.7–52.8) 
  > 3 years33.7(21.9–48.0)52.5(30.8–58.5) 
Analytes foundc
 Yes33.3(25.3–42.4)75.5(57.9–87.4)< 0.001
 No66.7(57.6–74.7)24.5(12.6–42.2) 
CD4 category (Pima)d
  ≤ 350 cells/μL57.8(42.8–71.5)28.2(15.7–45.2)0.018
  > 350 cells/μL42.2(28.6–57.2)71.9(54.8–84.3) 
  1. aWeights account for sampling, non-response, and age/sex of target population
  2. bBased on self-report
  3. cAssessed for EFV, LPV, NVP
  4. dAmong those for whom Pima CD4 results were available
  5. eRespondents may be mis-reporting status, be elite controllers, or on ART without understanding of their condition [35]